Smoking Cessation in Rural Hospitals



Status:Completed
Conditions:Smoking Cessation
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:11/30/2013
Start Date:March 2010
End Date:January 2014
Contact:Elly Biggerstaff
Email:ebiggerstaff@kumc.edu
Phone:913-588-2775

Use our guide to learn which trials are right for you!

Centralized Disease Management for Rural Hospitalized Smokers


Our long-term goal is to improve smoking cessation treatment for rural smokers. The
objective is to assess the effectiveness of a centralized disease management program for
hospitalized smokers that coordinates care across treatment settings and links smokers to
existing resources. Our central hypothesis is that Centralized Disease Management (CDM)
will increase the use of smoking cessation treatments and lead to greater long term smoking
cessation than Counseling alone. Demonstrating the effectiveness of a disease management
program and identifying the critical components of such a program will provide a basis for
improving the utilization of existing smoking cessation resources while enhancing the
treatment of rural hospitalized smokers.


The proposed study will use a randomized clinical trial design to examine the effectiveness
of centralized disease management (CDM) versus counseling alone (C) for smoking cessation.
Hospitalized smokers in 30 rural critical access hospitals will be randomly assigned to
either CDM (n=303) or C (n=303). Participants in both arms of the study will receive
in-hospital smoking cessation counseling via telephone followed by 4 outpatient
telephone-based counseling calls. The content and timing of these counseling calls are
designed to emulate models of smoking cessation counseling that have been previously shown
to be effective for hospitalized smokers. For recipients assigned to CDM, the counseling
will be streamlined to allow time on the calls for specific disease management
interventions, including screening for contraindications to pharmacotherapy and linking
medication choices to the smoker's insurance coverage. After completing calls with CDM
participants, the Tobacco Treatment Specialists will coordinate therapy with the patient's
health care providers by providing them with brief consultation reports, prepared order
sheets for inpatient treatment, and outpatient prescription requests. Six months
postdischarge, participants in both groups will be contacted again, and persistent or
relapsed smokers will be offered another cycle of the C or CDM intervention.

Assessments will be conducted at baseline and at months 3, 6, and 12. The primary outcome
of interest will be biochemically verified 7-day point prevalence abstinence at 12 months.
Secondary endpoints include number of quit attempts and number of cigarettes smoked (among
continuing smokers), pharmacotherapy utilization, duration of pharmacotherapy utilization,
and the extent of discussions with the healthcare provider. We will also examine the
marginal cost-effectiveness of the intervention.

Inclusion Criteria:

- Hospitalized in a participating rural hospital

- Aged 18 years or older

- Smoke cigarettes on >25 of the last 30 days

- Have a home address and telephone

- Willing to participate in phone assessments

Exclusion Criteria:

- Terminal medical condition with life expectancy <1 year

- Pregnant
We found this trial at
1
site
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials